Introduction People with Alzheimer's disease (AD) experience more rapid declines in their
ability to form hippocampal-dependent memories than cognitively normal healthy adults …

Background It has been well documented that atrophy of hippocampus and hippocampal
subfields is closely linked to cognitive decline in normal aging and patients with mild …

Several studies have investigated the differential vulnerability of hippocampal subfields
during aging and Alzheimer's disease (AD). Results were often contradictory, mainly …

Hippocampal atrophy and abnormal β‐Amyloid (Aβ) deposition are established markers of
Alzheimer's disease (AD). Nonetheless, longitudinal trajectory of Aβ‐associated …

While hippocampal atrophy and its regional susceptibility to Alzheimer's disease (AD) are
well reported at late stages of AD, studies of the asymptomatic stage of AD are limited but …

Atrophy within the hippocampus (HP) as measured by magnetic resonance imaging (MRI) is
a promising biomarker for the progression to Alzheimer's disease (AD). Subregions of the …

Background The hippocampus and hippocampal subfields have been found to be diversely
affected in Alzheimer's Disease (AD) and early stages of Alzheimer's disease by …

The hippocampus is one of the first regions to demonstrate atrophy during the prodromal
stage of Alzheimer's disease. Volumetric analysis of its individual subfields could provide …

The earliest sites of brain atrophy in Alzheimer's disease are in the medial temporal lobe,
following widespread cerebral cortical amyloid deposition. We assessed 74 cognitively …

We examined the relationship between hippocampal subfield volumes and cognitive decline
over a 4-year period in a healthy older adult population with the goal of identifying subjects …